CD40 is a prognostic marker in primary cutaneous malignant melanoma

American Journal of Pathology

Volumn 149, Issue 6, 1996, Pages 1953-1961

  Van Den Oord, Joost J ^a   Maes, Alex ^b   Stas, Marguerite ^b   Nuyts, Johan ^b   Battocchio, Simonetta ^a   Kasran, Ahmad ^b   Garmyn, Marjan ^b   De Wever, Ivo ^b   De Wolf Peeters, Chris ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CANCER IMMUNOLOGY; CANCER SURVIVAL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; MALE; MELANOMA; PRIORITY JOURNAL; PROGNOSIS; SKIN CANCER;

ANTIGENS, CD40; CD40 LIGAND; HUMANS; LIGANDS; MELANOMA; MEMBRANE GLYCOPROTEINS; PROGNOSIS; SKIN NEOPLASMS; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 0029835904     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Splawski JB, Fu SM, Lipsky PE: Immunoregulatory role of CD40 in human B cell differentiation. J Immunol 1993, 150:1276-1285
2. Alderson MR, Armitage RJ, Tough TW, Strockbine L, Fanslow WC, Spriggs MK: CD40 expression by human monocytes: regulation by cytokines and activation of monocytes by the ligand for CD40. J Exp Med 1993, 178:669-674
3. Schriever F, Freedman AS, Freeman G, Messner E, Lee G, Daley J, Nadler LM: Isolated human follicular dendritic cells display a unique antigenic phenotype. J Exp Med 1989, 169:2043-2058
4. Ling NR, MacLennan ICM, Mason DY: B-cell and plasma cell antigens: new and previously defined clusters. Leucocyte Typing III: White Cell Differentiation Antigens. Edited by AJ McMichael, PCL Beverley, S Cobbold, MJ Crumpton, W Gilks, FM Gotch, N Hogg, M Norton, N Ling, ICM MacLennan, DY Mason, C Milstein, D Spiegelhalter, H Waldmann. Oxford, Oxford University Press, 1987, pp 302-335
5. Valent P, Majdic O, Maurer D, Bodger M, Muhm M, Bettelheim P: Further characterization of surface membrane structures expressed on human basophils and mast cells. Int Arch Allergy Appl Immunol 1990, 91: 198-203
6. Karmann K, Hughes CCW, Schechner J, Fanslow WC, Pober JS: CD40 on human endothelial cells: inducibility by cytokines and functional regulation of adhesion molecule expression. Proc Natl Acad Sci USA 1995, 92: 4342-4346
7. Hollenbaugh D, Mischel-Petty N, Edwards CP, Simon JC, Denfeld RW, Kiener PA, Aruffo A: Expression of functional CD40 by vascular endothelial cells. J Exp Med 1995, 182:33-40
8. Galy AHM, Spits H: CD40 is functionally expressed on human thymic epithelial cells. J Immunol 1992, 149: 775-782
9. Ludewig B, Graf D, Gelderblom HR, Becker Y, Kroczek RA, Pauli G: Spontaneous apoptosis of dendritic cells is efficiently inhibited by TRAP (CD40-ligand) and TNF-α, but strongly enhanced by interleukin-10. Eur J Immunol 1995, 25:1943-1950
10. Young LS, Dawson CW, Brown KW, Rickinson AB: Identification of a human epithelial surface protein sharing an epitope with the C3d/Epstein-Barr virus receptor molecule of B lymphocytes. Int J Cancer 1989, 43:786-794
11. Möller P, Mielke B: Extensive analysis of tissue distribution of antigens defined by nex clustered and unclustered B-cell antibodies. Leucocyte Typing IV: White Cell Differentiation Antigens. Edited by W Knapp, B Dörken, WR Gilks, EP Rieber, RE Schmidt, H Stein, AEGK Von dem Borne. Oxford, Oxford University Press, 1989, pp 175-177
12. Yellin MJ, Winikoff S, Fortune SM, Baum D, Crow MK, Lederman S, Chess L: Ligation of CD40 on fibroblasts induces CD54 (ICAM-1) and CD106 (VCAM-1) up-regulation and IL-6 production and proliferation. J Leukocyte Biol 1995, 58:209-216
13. Stamenkovich I, Clark EA, Seed B: A B-lymphocyte activation molecule related to the nerve growth factor receptor and induced by cytokines in carcinomas. EMBO J 1989, 8:1403-1410
14. Paullie S, Ehlin-Henriksson B, Mellstedt H, Koho H, Ben-Aissa H, Perlmann P: A p50 surface antigen restricted to human urinary bladder carcinomas and B lymphocytes. Cancer Immunol Immunother 1985, 20: 23-28
15. Ledbetter JA, Clark EA, Norris N, Shu G, Hellstrom I: Expression of a functional B cell receptor Bp50 on carcinomas and carcinoma cell lines. Leucocyte Typing III: White Cell Differentiation Antigens. Edited by AJ McMichael, PCL Beverley, S Cobbold, MJ Crumpton, W Gilks, FM Gotch, N Hogg, M Norton, N Ling, ICM MacLennan, DY Mason, C Milstein, D Spiegelhalter, H Waldmann. Oxford, Oxford University Press, 1987, pp 432-435
16. Elder DE, Murphy G: Melanocytic tumors of the skin. Atlas of Tumor Pathology. Washington, DC, American Registry of Pathology, Armed Forces Institute of Pathology, 1990, pp 155-161
17. Moller P, Eichelmann A, Moldenhauer G: Surface molecules involved in B lymphocyte function. Virchows Arch A Pathol Anat Histopathol 1991, 419:365-372
18. de Boer M, Conroy L, Min HY, Kwekkeboom J: Generation of monoclonal antibodies to human lymphocyte cell surface antigens using insect cells expressing recombinant proteins. J Immunol Methods 1992, 152:15-23
19. Clark EA, Ledbetter JA: Activation of human B cells mediated through two distinct cell surface differentiation antigens, Bp35 and Bp50. Proc Natl Acad Sci USA 1986, 83:4494-4498
20. Fanslow WC, Clifford KN, Zappone J, Alderson MR, Armitage RJ: CD40 mAb M2 and M3 inhibit ligand binding and function. Leucocyte Typing V: White Cell Differentiation Antigens, vol 1. Edited by SF Schlossman, L Boumsell, W Gilks, JM Harlan, T Kishimoto, C Morimoto, J Ritz, S Shaw, R Silverstein, T Springer, TF Tedder, RF Todd. Oxford, Oxford University Press 1995, pp 555-558
21. Herlyn M: Human melanoma: development and progression. Cancer Metastasis Rev 1990, 9:101-112
22. Gruss H-J, Hirschstein D, Wright B, Ulrich D, Caligiuri MA, Barcos M, Strockbine L, Armitage RJ, Dower SK: Expression and function of CD40 on Hodgkin and Reed-Sternberg cells and the possible relevance for Hodgkin's disease. Blood 1994, 84:2305-2314
23. Rodeck U, Becker D, Herlyn M: Basic fibroblast growth factor in human melanoma. Cancer Cells 1991, 3:308-311
24. Smith GA, Farrah T, Goodwin RG: The tumor necrosis factor receptor superfamily of cellular and viral proteins: activation, costimulation, and death. Cell 1994, 76:959-962
25. Mattei S, Colombo MP, Melani C, Silvani A, Parmiani G, Herlyn M: Expression of cytokine/growth factors and their receptors in human melanoma and melanocytes. Int J Cancer 1994, 56:853-857
26. Marcheti D, Menter D, Jin L, Nakajima M, Nicolson GL: Nerve growth factor effects on human and mouse melanoma cell invasion and heparanase production. Int J Cancer 1993, 55:692-699
27. Gruss HJ, Ulrich D, Braddy S, Armitage RJ, Dower SK: Recombinant CD30 ligand and CD40 ligand share common biological activities on Hodgkin and Reed-Sternberg cells. Eur J Immunol 1995, 25:2083-2089
28. Hutchins D, Steel CM: Regulation of ICAM-1 (CD54) expression in human breast cancer cell lines by interleukin 6 and fibroblast-derived factors, Int J Cancer 1994, 58:80-84
29. Armitage RJ, Fanslow WC, Strockbine L, SatoTA, Clifford KN, Macduff BM, Anderson DM, Gimpel SD, Davis-Smith T, Maliszewski CR, Clark EA, Smith CA, Grabstein KH, Cosman D, Spriggs MK: Molecular and biological characterization of a murine ligand for CD40. Nature 1992, 357:80-82
30. Carbone A, Gloghini A, Gruss H-J, Pinto A: CD40 ligand is constitutively expressed in a subset of T cell lymphomas and on the microenvironmental reactive T cells of follicular lymphomas and Hodgkin's disease. Am J Pathol 1995, 147:912-922
31. Clement M-V, Stamenkovich I: Fas and tumor necrosis factor receptor-mediated cell death: similarities and distinctions. J Exp Med 1994, 180:557-567
32. Rabizadeh S, Bredesen DE: Is p75NGFR involved in developmental neural cell death? Dev Neurosci 1994, 16:207-211
33. Beeker JC, Brocker EB: Lymphocyte-melanoma interaction: role of surface molecules. Rec Res Cancer Res 1995, 139:205-214
34. Francisco JA, Gilliland LK, Stebbins MR, Norris NA, Ledbetter JA, Siagall CB: Activity of a single-chain immunotoxin that selectively kills lymphoma and other B-lineage cells expressing the CD40 antigen. Cancer Res 1995, 55:3099-3104